GlycoBac
Pre-clinicalGlycoBac provides assay services for Sf-rhabdovirus GlycoBac has developed a sensitive assay for infectious Sf-rhabdovirus particles using our proprietary Sf-RVN cell line. Contact us for additional information and pricing. GlycoBac partners with MilliporeSigma GlycoBac has partnered with
Founded
2016
Focus
BiologicsAntibodies
About
GlycoBac provides assay services for Sf-rhabdovirus GlycoBac has developed a sensitive assay for infectious Sf-rhabdovirus particles using our proprietary Sf-RVN cell line. Contact us for additional information and pricing. GlycoBac partners with MilliporeSigma GlycoBac has partnered with
Funding History
2Total raised: $17.5M
Series A$15MUndisclosedMar 15, 2023
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile